Evotec SE (EVO) Non-cash Items (2009 - 2026)
Evotec SE (EVO) posted Non-cash Items of $54474.8 for Q1 2026, down 35.03% sequentially from $83851.6 in Q3 2025, and up 57.07% YoY from $34681.7 in Q1 2025.
Evotec SE (EVO) Non-cash Items (2009 - 2026) Analysis & Trends
Evotec SE has reported Non-cash Items for 8 years, with the latest figure at $54474.8 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.66 Bn | 22.86 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,474.80 |
| Mar 31, 2026 | 54,474.80 |
| Sep 30, 2025 | 83,851.65 |
| Sep 30, 2025 | 83,851.65 |
| Jun 30, 2025 | 8,730.81 |
| Jun 30, 2025 | 8,730.81 |
| Mar 31, 2025 | 34,681.68 |
| Mar 31, 2025 | 34,681.68 |
| Sep 30, 2024 | 34,841.01 |
| Sep 30, 2024 | 34,841.01 |
| Jun 30, 2024 | 63,157.30 |
| Jun 30, 2024 | 63,157.30 |
| Mar 31, 2024 | 35,436.03 |
| Mar 31, 2024 | 35,436.03 |
| Sep 30, 2023 | 53,405.16 |
| Sep 30, 2023 | 53,405.16 |
| Jun 30, 2023 | 11,817.01 |
| Jun 30, 2023 | 11,817.01 |
| Mar 31, 2023 | 52,425.23 |
| Mar 31, 2023 | 52,425.23 |